Scientific Publications
Manuscripts
Prognostic impact of second primary malignancies in multiple myeloma: An ASCO CancerLinQ Discovery analysis of the modern era [CORRESPONDENCE]
American Journal of Hematology
Gibson S et al
Multiple myeloma in adolescent and young adults: An ASCO CancerLinQ and SEER analysis
Clinical Lymphoma, Myeloma and Leukemia
Gibson S et al
Health data sharing perspectives of patients receiving care in CancerLinQ-participating oncology practices
JCO Oncology Practice
Jagsi R et al
Real-world big-data: Strengths and weaknesses of ASCO's CancerLinQ Discovery® multiple myeloma dataset
American Journal of Hematology
DeStefano CB
Evaluation of cost-effectiveness of adjuvant osimertinib in patients with resected EGFR mutation-positive non-small cell lung cancer
PharmacoEconomics - Open
Verhoek A et al
Case studies for overcoming challenges in using big data in cancer
Cancer Research
Sweeney SM et al
Incidence of SARS-CoV-2 and subsequent mortality in a multi-site cohort of patients with cancer in the CancerLinQ Discovery database
JCO Oncology Practice
Ray et al
Retrospective analysis of real‐world management of EGFR‐mutated advanced NSCLC, after first‐line EGFR‐TKI treatment: US treatment patterns, attrition,…
Drugs Real World Outcomes
Nieva J et al
Abstracts
Pitfalls with analyses of real-world data: A look at ASCO’s CancerLinQ Discovery Multiple Myeloma dataset
ASCO Annual Meeting 2023
Shou K J et al
A real-world study of US patients with metastatic ovarian, fallopian tube, and peritoneal cancer (mOFPC) using integrated electronic health records (E…
ASCO Annual Meeting 2023
Avinash P B et al
The RESECT study: Factors associated with overall survival (OS) and relapse-free survival (RFS) among patients with stages I–III resected NSCLC withou…
ASCO Annual Meeting 2023
Gray J E et al
Real-world response endpoints in patients with mNSCLC treated with chemotherapy across real-world datasets
ASCO Annual Meeting 2023
McKelvey B A et al
Electronic health record (EHR) and genomics-based machine learning (ML) to predict therapeutic effectiveness among patients with hormone-receptor posi…
ASCO Annual Meeting 2023
Hathi D et al
Association between severe adverse event management and overall survival in patients treated with immune checkpoint inhibitor with advanced non–small-…
ASCO Annual Meeting 2023
Naidoo J et al
Development of natural language processing (NLP) models for extracting key features from unstructured notes to create real-world data (RWD) assets for…
ASCO Annual Meeting 2023
Agrawal S et al
Treatment patterns and outcomes among locally advanced cervical cancer patients receiving concurrent chemoradiotherapy
ASCO Annual Meeting 2023
Coutinho F et al
Enhancement in line of therapy (LoT) derivation from real-world data (RWD) from electronic health records (EHR) via integration of medical claims data
ASCO Annual Meeting 2023
Agrawal S et al
